KR101555119B1 - 알도스테론 신타제 억제제로서 유용한 피라졸 유도체 - Google Patents
알도스테론 신타제 억제제로서 유용한 피라졸 유도체 Download PDFInfo
- Publication number
- KR101555119B1 KR101555119B1 KR1020137032885A KR20137032885A KR101555119B1 KR 101555119 B1 KR101555119 B1 KR 101555119B1 KR 1020137032885 A KR1020137032885 A KR 1020137032885A KR 20137032885 A KR20137032885 A KR 20137032885A KR 101555119 B1 KR101555119 B1 KR 101555119B1
- Authority
- KR
- South Korea
- Prior art keywords
- mmol
- benzonitrile
- compound
- compounds
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161496657P | 2011-06-14 | 2011-06-14 | |
| US61/496,657 | 2011-06-14 | ||
| US201161506349P | 2011-07-11 | 2011-07-11 | |
| US61/506,349 | 2011-07-11 | ||
| PCT/US2012/041212 WO2012173849A1 (en) | 2011-06-14 | 2012-06-07 | Pyrazole derivatives useful as aldosterone synthase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20140009564A KR20140009564A (ko) | 2014-01-22 |
| KR101555119B1 true KR101555119B1 (ko) | 2015-09-22 |
Family
ID=46317515
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020137032885A Expired - Fee Related KR101555119B1 (ko) | 2011-06-14 | 2012-06-07 | 알도스테론 신타제 억제제로서 유용한 피라졸 유도체 |
Country Status (33)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170253577A1 (en) | 2014-07-04 | 2017-09-07 | Japan Tobacco Inc. | Method for producing indole compound |
| CN108586221B (zh) * | 2018-06-26 | 2021-03-02 | 常州制药厂有限公司 | 用于制备替卡格雷的中间体及其制备方法 |
| CN112409432B (zh) * | 2020-11-16 | 2023-07-07 | 陕西理工大学 | 一种依西美坦的合成方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57165369A (en) * | 1981-04-06 | 1982-10-12 | Teijin Ltd | Pyrazole derivative and its preparation |
| US4617307A (en) | 1984-06-20 | 1986-10-14 | Ciba-Geigy Corporation | Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors |
| US5057521A (en) | 1988-10-26 | 1991-10-15 | Ciba-Geigy Corporation | Use of bicyclic imidazole compounds for the treatment of hyperaldosteronism |
| GT200600381A (es) * | 2005-08-25 | 2007-03-28 | Compuestos organicos | |
| JPWO2007111175A1 (ja) | 2006-03-17 | 2009-08-13 | 日本碍子株式会社 | 目封止ハニカム構造体の製造方法 |
| EP2507234B1 (en) | 2009-11-30 | 2014-03-12 | Novartis AG | Imidazole derivatives as aldosterone synthase inhibitors |
| CN102711916B (zh) | 2010-01-14 | 2015-09-02 | 诺华股份有限公司 | 肾上腺激素调节剂的用途 |
-
2012
- 2012-06-04 AR ARP120101967A patent/AR086665A1/es unknown
- 2012-06-04 TW TW101120004A patent/TWI518073B/zh not_active IP Right Cessation
- 2012-06-07 US US13/490,530 patent/US8778984B2/en not_active Expired - Fee Related
- 2012-06-07 BR BR112013031873A patent/BR112013031873A2/pt not_active IP Right Cessation
- 2012-06-07 MX MX2013014790A patent/MX336042B/es unknown
- 2012-06-07 EA EA201391655A patent/EA201391655A1/ru unknown
- 2012-06-07 HR HRP20150939TT patent/HRP20150939T1/hr unknown
- 2012-06-07 PT PT127279842T patent/PT2721009E/pt unknown
- 2012-06-07 PL PL12727984T patent/PL2721009T3/pl unknown
- 2012-06-07 RS RS20150619A patent/RS54269B1/sr unknown
- 2012-06-07 CA CA2836804A patent/CA2836804C/en not_active Expired - Fee Related
- 2012-06-07 AU AU2012271023A patent/AU2012271023A1/en not_active Abandoned
- 2012-06-07 ES ES12727984.2T patent/ES2548210T3/es active Active
- 2012-06-07 CN CN201280028717.6A patent/CN103596930B/zh not_active Expired - Fee Related
- 2012-06-07 ME MEP-2015-131A patent/ME02223B/me unknown
- 2012-06-07 PH PH1/2013/502597A patent/PH12013502597A1/en unknown
- 2012-06-07 JP JP2014515877A patent/JP5890012B2/ja not_active Expired - Fee Related
- 2012-06-07 HU HUE12727984A patent/HUE026461T2/en unknown
- 2012-06-07 WO PCT/US2012/041212 patent/WO2012173849A1/en not_active Ceased
- 2012-06-07 DK DK12727984.2T patent/DK2721009T3/en active
- 2012-06-07 PE PE2013002810A patent/PE20140606A1/es not_active Application Discontinuation
- 2012-06-07 SI SI201230283T patent/SI2721009T1/sl unknown
- 2012-06-07 SG SG2013082367A patent/SG194822A1/en unknown
- 2012-06-07 KR KR1020137032885A patent/KR101555119B1/ko not_active Expired - Fee Related
- 2012-06-07 EP EP12727984.2A patent/EP2721009B1/en active Active
-
2013
- 2013-11-18 IL IL229485A patent/IL229485A0/en unknown
- 2013-11-18 CR CR20130601A patent/CR20130601A/es unknown
- 2013-12-02 DO DO2013000284A patent/DOP2013000284A/es unknown
- 2013-12-10 CL CL2013003536A patent/CL2013003536A1/es unknown
- 2013-12-11 GT GT201300307A patent/GT201300307A/es unknown
- 2013-12-11 CO CO13290174A patent/CO6821955A2/es active IP Right Grant
- 2013-12-13 EC ECSP13013080 patent/ECSP13013080A/es unknown
-
2015
- 2015-09-11 CY CY20151100789T patent/CY1116687T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2748251C (en) | Bicyclic heterocyclic compound for use as a sensory neuron specific sodium channel inhibitor | |
| RU2743098C2 (ru) | Новые производные аммония, способ их получения и фармацевтические композиции, содержащие их | |
| EP2655378B1 (en) | Compounds and their use as bace inhibitors | |
| JP2022527298A (ja) | Ｓｔａｔ３の低分子分解誘導剤 | |
| NZ583515A (en) | Imidazole-pyridine derivative featuring a 1,2,4-triazole ring fused to a 5-7 membered ring, for treating a disease caused by amyloid-beta such as Alzheimer's, dementia, Down's syndrome, and amyloidosis | |
| TW202330538A (zh) | 螺環化合物 | |
| TW202304877A (zh) | 內醯胺作為ｃｂｌ—ｂ抑制劑 | |
| US5212177A (en) | Indole and benzimidazole-substituted dihydropyrimidine derivatives | |
| WO2025076044A1 (en) | Kras proteolysis targeting chimeras | |
| EP4151634A1 (en) | Preparation of biaryl ring-linked aromatic heterocyclic derivative as immunomodulator and use thereof | |
| KR101555119B1 (ko) | 알도스테론 신타제 억제제로서 유용한 피라졸 유도체 | |
| WO2020142227A1 (en) | Estrogen receptor protein degraders | |
| CN118434735A (zh) | 8-氮杂喹唑啉作为脑渗透sos1抑制剂 | |
| CN108368094B (zh) | 用于局部药物递送的非甾体类糖皮质激素受体调节剂 | |
| JP6884973B2 (ja) | 疼痛に対して活性を有するオキサジアザスピロ化合物 | |
| WO2022165512A1 (en) | Orally active leukemia inhibitory factor (lif) antagonists for the treatment of cancer | |
| KR20230154194A (ko) | 신장 섬유증의 치료를 위한 HIPK2의 옥사디아졸릴 디하이드로피라노[2,3-b]피리딘 억제제 | |
| JP2018531263A6 (ja) | 疼痛に対して活性を有するオキサジアザスピロ化合物 | |
| NZ617642B2 (en) | Pyrazole derivatives useful as aldosterone synthase inhibitors | |
| WO2025074249A1 (en) | Nitrogen-linked benzisoxazole sulfonamide derivatives for the treatment of cancer | |
| WO2006104008A1 (ja) | ウレア誘導体、それを含有する医薬組成物およびそれらの医薬用途 | |
| HK1190721B (en) | Compounds and their use as bace inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U12-oth-PR1002 Fee payment year number: 1 |
|
| PG1601 | Publication of registration |
St.27 status event code: A-4-4-Q10-Q13-nap-PG1601 |
|
| LAPS | Lapse due to unpaid annual fee | ||
| PC1903 | Unpaid annual fee |
St.27 status event code: A-4-4-U10-U13-oth-PC1903 Not in force date: 20180917 Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE |
|
| PC1903 | Unpaid annual fee |
St.27 status event code: N-4-6-H10-H13-oth-PC1903 Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE Not in force date: 20180917 |